Noda C, Nakamura T, Ichihara A
J Biol Chem. 1983 Feb 10;258(3):1520-5.
In primary cultures of rat hepatocytes, addition of dexamethasone (10 microM) plus glucagon (0.5 microM) caused several-fold increases in the activities of serine dehydratase (EC 4.2.1.13), tryptophan oxygenase (EC 1.13.11.11), and tyrosine aminotransferase (EC 2.6.1.5) in 24 h. These inductions were inhibited by insulin. Addition of epinephrine or phenylephrine at 10 microM blocked these inductions. This suppressive effect of adrenergic compounds was completely abolished by the alpha-adrenergic antagonist phenoxybenzamine at 10 microM. Immunochemical analysis with antiserum to serine dehydratase showed that the changes in enzyme activity were due to changes in the amount of enzyme. Epinephrine was effective even when glucagon was replaced by dibutyryl cAMP (50 microM), indicating that alpha-adrenergic suppression of enzyme inductions was mediated by a cAMP-independent mechanism. Furthermore, the findings that prazosin antagonized this epinephrine effect, but yohimbine did not, indicate that the alpha 1- but not the alpha 2-receptor is involved in this inhibition. However, the alpha-adrenergic effect was different from that of insulin in that, unlike the latter, the inductions of tryptophan oxygenase and tyrosine amino-transferase by dexamethasone alone were not inhibited. The alpha-adrenergic action apparently counteracts the action of glucagon and cAMP. For determination of the beta-adrenergic effect of catecholamines on the inductions of enzymes, beta-adrenergic compounds were tested without glucagon. Isoproterenol or epinephrine plus phenoxybenzamine induced tryptophan oxygenase and tyrosine aminotransferase. Induction of serine dehydratase was shown by isoproterenol only in the presence of 1-methyl-3-isobutylxanthine, an inhibitor of phosphodiesterase. These results indicate that catecholamines play dual roles in regulation of the amount of enzyme through their alpha 1- and beta-adrenergic actions.
在大鼠肝细胞原代培养物中,添加地塞米松(10微摩尔)加胰高血糖素(0.5微摩尔)在24小时内使丝氨酸脱水酶(EC 4.2.1.13)、色氨酸加氧酶(EC 1.13.11.11)和酪氨酸转氨酶(EC 2.6.1.5)的活性增加了几倍。这些诱导作用被胰岛素抑制。添加10微摩尔的肾上腺素或去氧肾上腺素可阻断这些诱导作用。10微摩尔的α-肾上腺素能拮抗剂酚苄明可完全消除肾上腺素能化合物的这种抑制作用。用抗丝氨酸脱水酶抗血清进行的免疫化学分析表明,酶活性的变化是由于酶量的变化。即使将胰高血糖素替换为二丁酰环磷腺苷(50微摩尔),肾上腺素仍有作用,这表明α-肾上腺素能对酶诱导的抑制是由一种不依赖环磷腺苷的机制介导的。此外,哌唑嗪能拮抗这种肾上腺素作用,而育亨宾则不能,这表明参与这种抑制作用的是α1而非α2受体。然而,α-肾上腺素能作用与胰岛素的作用不同,与后者不同的是,单独用地塞米松诱导色氨酸加氧酶和酪氨酸转氨酶不会被抑制。α-肾上腺素能作用显然抵消了胰高血糖素和环磷腺苷的作用。为了测定儿茶酚胺对酶诱导的β-肾上腺素能作用,在没有胰高血糖素的情况下测试了β-肾上腺素能化合物。异丙肾上腺素或肾上腺素加酚苄明可诱导色氨酸加氧酶和酪氨酸转氨酶。仅在存在磷酸二酯酶抑制剂1-甲基-3-异丁基黄嘌呤的情况下,异丙肾上腺素才显示出对丝氨酸脱水酶的诱导作用。这些结果表明,儿茶酚胺通过其α1和β-肾上腺素能作用在调节酶量方面发挥双重作用。